PEXIOVEQ Trademark

Trademark Overview

On Friday, December 28, 2018, a trademark application was filed for PEXIOVEQ with the United States Patent and Trademark Office. The USPTO has given the PEXIOVEQ trademark a serial number of 88243807. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 23, 2023. This trademark is owned by SillaJen, Inc.. The PEXIOVEQ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer

Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer
pexioveq

General Information

Serial Number88243807
Word MarkPEXIOVEQ
Filing DateFriday, December 28, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements

Goods and ServicesOncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer
Goods and ServicesProviding information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 18, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSillaJen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 04525
KR
Party NameSillaJen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBusan 46508
KR

Trademark Events

Event DateEvent Description
Monday, January 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, June 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022SOU EXTENSION 5 GRANTED
Tuesday, June 14, 2022SOU EXTENSION 5 FILED
Thursday, June 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, December 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 9, 2021SOU EXTENSION 4 GRANTED
Thursday, December 9, 2021SOU EXTENSION 4 FILED
Thursday, December 9, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 14, 2021SOU EXTENSION 3 GRANTED
Monday, June 14, 2021SOU EXTENSION 3 FILED
Monday, June 14, 2021SOU TEAS EXTENSION RECEIVED
Friday, March 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 26, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 26, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 17, 2020SOU EXTENSION 2 GRANTED
Tuesday, November 17, 2020SOU EXTENSION 2 FILED
Tuesday, November 17, 2020SOU TEAS EXTENSION RECEIVED
Saturday, April 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 2, 2020SOU EXTENSION 1 GRANTED
Thursday, April 2, 2020SOU EXTENSION 1 FILED
Thursday, April 2, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 18, 2019ASSIGNED TO LIE
Monday, September 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 30, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 27, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 27, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 20, 2019ASSIGNED TO EXAMINER
Friday, January 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 1, 2019NEW APPLICATION ENTERED

Related Keywords

pexioveq cancer diagnosis treatment prevention pharmaceutical biologic medical field scientific research